-
公开(公告)号:US10745400B2
公开(公告)日:2020-08-18
申请号:US16353745
申请日:2019-03-14
Applicant: Vanderbilt University
Inventor: Corey R. Hopkins , Matthew Ritter , Charles C. Hong , Anish Vadukoot , Darren W. Engers , Craig W. Lindsley
IPC: C07D471/10 , A61K31/438 , C07D471/04 , A61P35/00
Abstract: Provided herein are substituted imidazo[1,2-a]pyridines useful as inhibitors of BMP signaling. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted imidazo[1,2-a]pyridines.
-
公开(公告)号:US20200054643A1
公开(公告)日:2020-02-20
申请号:US16478772
申请日:2018-01-18
Applicant: Vanderbilt University
Inventor: Corey R. Hopkins , Charles C. Hong , Craig W. Lindsley , Darren W. Engers
IPC: A61K31/5377 , A61K31/4725 , A61K31/437 , A61K31/4709 , A61K31/498 , A61K31/496 , A61K31/506 , A61K31/519 , A61K31/4985
Abstract: The present invention provides small molecule inhibitors of BMP signaling that are useful for treating diseases or conditions associated with BMP signaling, including cancers of the central nervous system.
-
公开(公告)号:US20170313701A1
公开(公告)日:2017-11-02
申请号:US15652100
申请日:2017-07-17
Applicant: Vanderbilt University
Inventor: Corey R. Hopkins , Charles C. Hong , Craig W. Lindsley , Darren W. Engers
IPC: C07D471/04 , A61K31/519 , A61K31/4709 , A61K31/5025 , C07D519/00 , C07D487/04
CPC classification number: C07D471/04 , A61K31/4709 , A61K31/5025 , A61K31/519 , C07D487/04 , C07D519/00
Abstract: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.
-
公开(公告)号:US20170190717A1
公开(公告)日:2017-07-06
申请号:US15452551
申请日:2017-03-07
Applicant: Vanderbilt University
Inventor: Charles C. Hong , Charles H. Williams , Jonathan Hempel , TK Feaster , Don H. Rubin , Gary Sulikowski , Jijun Hao , Audrey Frist
IPC: C07D495/14 , A61K9/00 , C07D495/04 , A61K31/519 , A61K31/381 , C07D409/12 , A61K31/517 , C07D471/04 , C07D333/38 , A61K45/06 , A61K31/5377
CPC classification number: C07D495/14 , A61K9/0019 , A61K9/0078 , A61K31/381 , A61K31/517 , A61K31/519 , A61K31/5377 , A61K45/06 , C07D333/38 , C07D409/12 , C07D471/04 , C07D495/04 , A61K2300/00
Abstract: Compounds and compositions, and methods of use thereof, are provided and have utility in inhibiting hedgehog signaling and/or phosphodiesterase-4 activity.
-
公开(公告)号:US20190284183A1
公开(公告)日:2019-09-19
申请号:US16353745
申请日:2019-03-14
Applicant: Vanderbilt University
Inventor: Corey R. Hopkins , Matthew Ritter , Charles C. Hong , Anish Vadulkoot , Darren Engers , Craig W. Lindsley
IPC: C07D471/04
Abstract: Provided herein are substituted imidazo[1,2-a]pyridines useful as inhibitors of BMP signaling. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted imidazo[1,2-a]pyridines.
-
公开(公告)号:US10196392B2
公开(公告)日:2019-02-05
申请号:US15652100
申请日:2017-07-17
Applicant: Vanderbilt University
Inventor: Corey R. Hopkins , Charles C. Hong , Craig W. Lindsley , Darren W. Engers
IPC: A61K31/4709 , A61K31/5025 , A61K31/519 , C07D471/04 , C07D487/04 , C07D519/00
Abstract: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.
-
公开(公告)号:US20190218214A1
公开(公告)日:2019-07-18
申请号:US16333201
申请日:2017-09-14
Applicant: Vanderbilt University
Inventor: Corey R. Hopkins , Charles C. Hong , Craig W. Lindsley , Darren W. Engers
IPC: C07D471/04 , C07D519/00 , A61P35/00
CPC classification number: C07D471/04 , A61P35/00 , C07D519/00
Abstract: Provided herein are substituted imidazo[1,2-a]pyridines useful as inhibitors of BMP signaling. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted imidazo [1,2-a] pyridines.
-
公开(公告)号:US10329304B2
公开(公告)日:2019-06-25
申请号:US15452551
申请日:2017-03-07
Applicant: Vanderbilt University
Inventor: Charles C. Hong , Charles H. Williams , Jonathan Hempel , T K Feaster , Don H. Rubin , Gary Sulikowski , Jijun Hao , Audrey Frist
IPC: C07D495/14 , C07D495/04 , C07D409/12 , C07D471/04 , C07D333/38 , A61K45/06 , A61K9/00 , A61K31/519 , A61K31/5377 , A61K31/517 , A61K31/381
Abstract: Compounds and compositions, and methods of use thereof, are provided and have utility in inhibiting hedgehog signaling and/or phosphodiesterase-4 activity.
-
公开(公告)号:US09738636B2
公开(公告)日:2017-08-22
申请号:US14432472
申请日:2013-03-15
Applicant: Vanderbilt University
Inventor: Corey R. Hopkins , Charles C. Hong , Craig W. Lindsley , Darren W. Engers
IPC: C07D471/04 , A61K31/4709 , A61K31/5025 , A61K31/519 , C07D487/04 , C07D519/00
CPC classification number: C07D471/04 , A61K31/4709 , A61K31/5025 , A61K31/519 , C07D487/04 , C07D519/00
Abstract: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.
-
10.
公开(公告)号:US20160068525A1
公开(公告)日:2016-03-10
申请号:US14432472
申请日:2013-03-15
Applicant: VANDERBILT UNIVERSITY
Inventor: Corey R. Hopkins , Charles C. Hong , Craig W. Lindsley , Darren W. Engers
IPC: C07D471/04 , C07D519/00 , C07D487/04
CPC classification number: C07D471/04 , A61K31/4709 , A61K31/5025 , A61K31/519 , C07D487/04 , C07D519/00
Abstract: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.
Abstract translation: 本发明提供BMP信号传导的小分子抑制剂。 这些化合物可用于调节细胞生长,分化,增殖和凋亡,因此可用于治疗与BMP信号相关的疾病或病症,包括炎症,心血管疾病,血液病,癌症和骨骼疾病,以及 用于调节细胞分化和/或增殖。
-
-
-
-
-
-
-
-
-